Weihua Yan
16 Jiangsu Road
Qingdao, 266005, China
Qingdao, 266005, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Sinonasal metastasis as the initial presentation of renal clear cell carcinoma: a dual-center retrospective study and proposed diagnostic algorithm.
Journal: Frontiers in oncology
Published: December 12, 2025
Next-generation sequencing identifies potential mechanisms of primary resistance to trastuzumab-containing therapies in HER2-positive gastric cancer: Analysis based on real-world data and online databases.
Journal: Human vaccines & immunotherapeutics
Published: September 09, 2025
Multi-omics analysis of the dynamic role of STAR+ cells in regulating platinum-based chemotherapy responses and tumor microenvironment in serous ovarian carcinoma.
Journal: Frontiers in pharmacology
Published: December 15, 2024
Neoadjuvant PD-(L)1 blockade with or without chemotherapy versus chemotherapy alone in mismatch repair-deficient, potentially resectable stage III-IVA gastric cancer patients: a single-center retrospective study.
Journal: World journal of surgical oncology
Published: August 05, 2024
Optimal Treatments for NSCLC Patients Harboring Primary or Acquired MET Amplification.
Journal: Technology in cancer research & treatment
Published: September 23, 2022
Lidocaine attenuates hypoxia/reoxygenation‑induced inflammation, apoptosis and ferroptosis in lung epithelial cells by regulating the p38 MAPK pathway.
Journal: Molecular medicine reports
Published: June 24, 2021
Case Report: Primary and Acquired Resistance Mechanisms of Nimotuzumab in Advanced Esophageal Squamous Cell Carcinoma Revealed by Targeted Sequencing.
Journal: Frontiers in oncology
Published: June 20, 2020
KIT/PDGFRA/KDR amplification defines a novel molecular subtype of adenoid cystic carcinoma patients who may benefit from treatment with tyrosine kinase inhibitors.
Journal: Translational cancer research
Published: January 17, 2020
Publisher Correction: Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay.
Journal: Scientific reports
Published: January 17, 2018
Comprehensive Molecular Characterization of Young Chinese Patients with Lung Adenocarcinoma Identified a Distinctive Genetic Profile.
Journal: The oncologist
Published: November 29, 2017
Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay.
Journal: Scientific reports
Published: July 21, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026